ODI Pharma AB
ODI | SPGR
Overview
Corporate Details
- ISIN(s):
- SE0013409760 (+2 more)
- LEI:
- 8945001MNHCQFIP27M14
- Country:
- Sweden
- Address:
- Östermalmstorg 1, 114 42 Stockholm
- Website:
- https://www.odipharma.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
ODI Pharma is a producer and supplier of medical cannabis products. The business is run through subsidiaries and partners where sales go through wholesale distributors and pharmacies. The products are used for the treatment of multiple sclerosis, chronic pain, and chemotherapy. ODI Pharma operates in the European market and is headquartered in Stockholm.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Dermapharm Holding SE | Germany | DMP | |
|
Dicot Pharma AB | Sweden | DICOTBT | |
|
EARNZ PLC | United Kingdom | EARN | |
|
Eevia Health Plc | Finland | EEVIA | |
|
Egetis Therapeutics | Sweden | EGTX | |
|
ELARIS AG | Germany | ELS | |
|
Enervit | Italy | ENV | |
|
Enorama Pharma AB | Sweden | ERMA | |
|
Enzymatica AB | Sweden | ENZY | |
|
EQL Pharma AB | Sweden | EQL |